Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Maier P, Bohringer D, Reinhard T . Clear graft survival and immune reactions following emergency keratoplasty. Graefes Arch Clin Exp Ophthalmol 2007; 245 (3): 351–359.
Szaflik JP, Major J, Izdebska J, Lao M, Szaflik J . Systemic immunosuppression with mycophenolate mofetil to prevent corneal graft rejection after high-risk penetrating keratoplasty: a 2-year follow-up study. Graefes Arch Clin Exp Ophthalmol 2016; 254 (2): 307–314.
Cruz GK, da Silva SB, de Azevedo IC, Carvalho DP, Meireles PF, Junior MA et al. Epidemiological Profile of Patients Undergoing Urgent Corneal Transplant in a Referral Center in Northeastern Brazil. Transplant Proc 2016; 48 (7): 2366–2370.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Croghan, C., Chou, CY., Gajree, S. et al. Emergency therapeutic penetrating keratoplasty in a tertiary ophthalmic care facility. Eye 32, 655–657 (2018). https://doi.org/10.1038/eye.2017.216
Published:
Issue date:
DOI: https://doi.org/10.1038/eye.2017.216
This article is cited by
-
Outcomes after Descemet membrane endothelial keratoplasty over a period of 7 years at a tertiary referral center: endothelial cell density, central corneal thickness, and visual acuity
Graefe's Archive for Clinical and Experimental Ophthalmology (2021)
